We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$446B
AUM Growth
+$49.9B
Cap. Flow
+$20.1B
Cap. Flow %
4.51%
Top 10 Hldgs %
17.27%
Holding
6,869
New
821
Increased
2,556
Reduced
2,333
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 14.59%
2 Consumer Discretionary 9.73%
3 Financials 8.55%
4 Healthcare 8.03%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEG icon
2526
Aegon
AEG
$14B
$11.5M ﹤0.01%
2,966,100
+48,820
+2% +$208K
EWA icon
2527
iShares MSCI Australia ETF
EWA
$1.43B
$11.5M ﹤0.01%
441,743
+325,910
+281% +$8.58M
MRC
2528
DELISTED
MRC Global
MRC
$11.5M ﹤0.01%
1,220,765
-275,988
-18% -$2.8M
RCUS icon
2529
Arcus Biosciences
RCUS
$3.58B
$11.4M ﹤0.01%
416,731
-164,720
-28% -$4.7M
HBI
2530
DELISTED
Hanesbrands
HBI
$11.4M ﹤0.01%
612,216
+58,816
+11% +$1.16M
ALXN
2531
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
$11.4M ﹤0.01%
62,200
-21,900
-26% -$3.76M
ALDX icon
2532
Aldeyra Therapeutics
ALDX
$91.7M
$11.4M ﹤0.01%
1,007,619
+931,972
+1,232% +$11.2M
HA
2533
DELISTED
Hawaiian Holdings, Inc.
HA
$11.4M ﹤0.01%
468,384
+256,850
+121% +$6.63M
UNH icon
2534
CALL
UnitedHealth
UNH
$371B
$11.4M ﹤0.01%
28,500
-49,700
-64% -$19.8M
NXPI icon
2535
PUT
NXP Semiconductors
NXPI
$59.7B
$11.4M ﹤0.01%
+55,400
New +$11.1M
TTM
2536
PUT
DELISTED
Tata Motors Limited
TTM
$11.4M ﹤0.01%
+500,000
New +$10.7M
BOAS
2537
DELISTED
BOA Acquisition Corp.
BOAS
$11.4M ﹤0.01%
+1,177,305
New +$11.4M
PTCT icon
2538
PTC Therapeutics
PTCT
$5.75B
$11.4M ﹤0.01%
269,314
-244,789
-48% -$10.5M
CIO
2539
DELISTED
City Office REIT
CIO
$11.4M ﹤0.01%
913,370
-25,462
-3% -$295K
AZO icon
2540
CALL
AutoZone
AZO
$49B
$11.3M ﹤0.01%
7,600
-1,700
-18% -$2.46M
QSR icon
2541
Restaurant Brands International
QSR
$25.6B
$11.3M ﹤0.01%
175,967
-501,135
-74% -$33.8M
VCEL icon
2542
Vericel Corp
VCEL
$2.37B
$11.3M ﹤0.01%
215,641
-175,846
-45% -$10M
ACAH
2543
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$11.3M ﹤0.01%
+1,171,910
New +$11.4M
CLDX icon
2544
Celldex Therapeutics
CLDX
$3.04B
$11.3M ﹤0.01%
338,055
-130,826
-28% -$3.59M
DOO
2545
Bombardier Recreational Products
DOO
$4.67B
$11.3M ﹤0.01%
144,247
+25,506
+21% +$2.16M
EC icon
2546
Ecopetrol
EC
$33.3B
$11.3M ﹤0.01%
772,850
+449,292
+139% +$5.73M
MNDY icon
2547
monday.com
MNDY
$3.85B
$11.3M ﹤0.01%
+50,410
New +$11M
GRDI
2548
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
$11.3M ﹤0.01%
1,162,911
+1,012,216
+672% +$9.82M
KSU
2549
PUT
DELISTED
Kansas City Southern
KSU
$11.3M ﹤0.01%
+39,700
New +$11.5M
OZK icon
2550
Bank OZK
OZK
$5.7B
$11.2M ﹤0.01%
266,486
-112,761
-30% -$4.7M

Similar funds

Goldman Sachs's Q2 2021 Portfolio in Review

As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.

  • Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
  • Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
  • Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
  • Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
  • Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
  • Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
  • Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.